The Post reports on different views on lobbyists’ wins and losses in the health care reform debate. Either way, pharmaceutical lobbyists won new federal policies they coveted and set a trajectory for long-term industry growth. Privately, several of them say … Continue reading
Daily Archives: March 29, 2010
The Post covers the status of an open government initiative (and lobbyist fees) in Maryland. A majority of lawmakers in both chambers signed on as co-sponsors, and the bills included a funding mechanism (increased fees on lobbyists) to pay for … Continue reading